2013 Apr 15 Annual Report 2012 - Phosphagenics

Additional Shareholder Information continued
BUY-BACK
The Company has not undertaken any share buy-back plans during or since the year ended
31 December 2012
SUBSTANTIAL SHAREHOLDINGS
The following Substantial Shareholdings (‘SSH’) have been declared to the Company :
Holder of relevant interest
Entitlement to
No. securities
Date of SSH
Notice Form No.
Orbis Global Equity Fund Ltd 133,609,911 22.03.2012 604
Harry Rosen 64,226,436 16.01.2012 604
Ross G Copeland 45,175,335 14.09.2011 603
Broking Commissions: Not applicable.
UNQUOTED OPTIONS
OPTIONS : EXPIRED 31 MARCH 2013
As at closed of buisness on 31 March 2013 the Company had received applications for the exercise of
250,000 options at an exercise price of $0.142 an option.
114
As such, a total of 4,750,000 March 31 2013 options automatically lapsed through non-exercise.
Following clearance of funds the Company will be issuing 250,000 new ordinary fully paid shares arising
from the the exercise of the 31 March 2013 options.
VOTING RIGHTS : The 31 March 2013 Options carried no voting rights.
OPTIONS : 22 MAY 2014
Twenty Largest Holdings :
(expiring 22 May 2014 & exercisable
at 17.0cents each.)
Number
Options Held
% Issued
Capital
Ranking
Mr K Poutakidis 1,000,000 100.00 1
The options are fully vested and may be exercised at any time before the stated expiry date.
VOTING RIGHTS : Options carry no voting rights.
Employee Share Option Plan (“The Plan”)
As at the date of this report the Company has on issue under the terms & conditions of the PLAN an
aggregate of 3.25 million ESOP options with various expiry dates and exercise prices. The options may be
exercised at any time before the stated expiry date after they have become fully vested. As at the date of
this report no ESOP options have been exercised.
A summary of the options issued under the PLAN is:
Granted 15,900,000
Less Lapsed -12,650,000
Number of options now on issue 3,250,000
Number fully vested options 3,250,000
Number non-vested options -
3,250,000
On a fully diluted basis the number of unexercised ESOP options (3,250,000) represents 0.31 per cent of
all issued securities
VOTING RIGHTS : ESOP Options carry no voting rights.
PHOSPHAGENICS ANNUAL REPORT 2012